Revenue (Quarterly)

Revenue: The sum of all revenue fields included for a company's operating activities.

BioLineRx Ltd. (BLRX) had Revenue of $0.43M for the most recently reported fiscal quarter, ending 2025-09-30.

Quarterly Annual

Figures for fiscal quarter ending 2025-09-30

Income Statement Financials
Revenue	$0.43M
Net Income	$-0.98M
Cost of Goods Sold	$0.08M
Gross Profit	$0.34M
Operating Expenses	$2.63M
Operating Income	$-2.21M
Non-Operating Income/Expense	$1.23M
Pre-Tax Income	$-0.98M
Normalized Pre-Tax Income	$-0.98M
Income after Taxes	$-0.98M
Income from Continuous Operations	$-0.98M
Consolidated Net Income/Loss	$-0.98M
Normalized Income after Taxes	$-0.98M
EBIT	$-2.21M
EBITDA	$-2.09M
Weighted-Average Shares Outstanding (Basic)	4.34M
Weighted-Average Shares Outstanding (Diluted)	4.34M
Earnings per Share (EPS) (Basic)	$0.00
Earnings per Share (EPS) (Diluted)	$0.00
Balance Sheet Financials
Current Assets	$28.52M
Property, Plant, and Equipment	$0.17M
Long-Term Assets	$11.28M
Total Assets	$39.80M
Current Liabilities	$13.67M
Long-Term Debt	$5.60M
Long-Term Liabilities	$6.60M
Total Liabilities	$20.27M
Common Equity	$19.53M
Tangible Shareholders Equity	$9.14M
Shareholders Equity	$19.53M
Common Shares Outstanding	4.35M
Cash Flow Statement Financials
Cash Flow from Operating Activities	$-4.87M
Cash Flow from Investing Activities	$-8.21M
Cash Flow from Financial Activities	$10.14M
Beginning Cash	$10.44M
End Cash	$7.91M
Increase/Decrease in Cash	$-2.52M
Stock-Based Compensation	$0.35M
Common Stock Dividends Paid	--
Preferred Stock Dividends Paid	--
Fundamental Metrics & Ratios
Current Ratio	2.09
Non-Performing Assets / Total Loans	--
Loan Loss Reserves / Non-Performing Loans	--
Debt to Capital Ratio	0.22
Debt to Equity Ratio	0.52
Gross Margin	80.33%
Operating Margin	-516.86%
EBIT Margin	-516.86%
EBITDA Margin	--
Pre-Tax Profit Margin	-228.81%
Profit Margin	-228.81%
Free Cash Flow	$-4.87M
Loss Ratio	--
Expense Ratio	--
Combined Ratio	--
Asset Turnover	0.01
Inventory Turnover	0.04
Receiveable Turnover	0.61
Days Sales in Receivables	147.33
Return on Equity	-5.00%
Return on Tangible Equity	-10.68%
Return on Assets	-2.45%
Return on Investments	-3.89%
Book Value Per Share	$4.49
Free Cash Flow per Share	$-1.12
Operating Cash Flow per Share	$-1.12

Data from Zacks Investment Research, Inc.